Published 30 day notice

49473

Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name

Type of respondents

PCP Lecture Evaluation (Attachment 3) ...................................................

PCP Final Course Evaluation (Attachment 5) ...........................................

NIH Summer Course in Clinical and Translational Research Course
Evaluation (Attachment 6).
Sabbatical in Clinical Research Management Course Evaluation (Attachment 7).
Ethical and Regulatory Aspects of Clinical Research (Asynchronous/Online) Course (Attachment 8).
Total ....................................................................................................

Dated: July 25, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–16184 Filed 7–28–23; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

ddrumheller on DSK120RN23PROD with NOTICES1

National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
This is a hybrid meeting held inperson and virtually and is open to the
public as indicated below. Individuals
who plan to attend in-person or view
the virtual meeting and need special
assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from
https://www.genome.gov/about-nhgri/
Institute-Advisors/National-AdvisoryCouncil-for-Human-Genome-Research.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

VerDate Sep<11>2014

18:11 Jul 28, 2023

Jkt 259001

Estimated
number of
respondents

Frm 00040

Average
burden per
response
(in hours)

Total
annual
burden
hours

General Public ........................
Healthcare Professionals ........
Students ..................................
General Public ........................
Healthcare Professionals ........
Students ..................................
General Public ........................
Healthcare Professionals ........

250
750
500
250
750
500
250
20

1
1
1
1
1
1
1
1

5/60
5/60
5/60
5/60
5/60
5/60
5/60
5/60

21
63
42
21
63
42
21
2

Healthcare Professionals ........

20

1

5/60

2

Healthcare Professionals ........
Students ..................................
General Public ........................

100
50
100

1
1
1

5/60
5/60
5/60

8
4
8

.................................................

........................

9,790

....................

820

Name of Committee: National Advisory
Council for Human Genome Research.
Date: September 18–19, 2023.
Closed: September 18, 2023, 9:00 a.m. to
10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892.
Open: September 18, 2023, 10:30 a.m. to
6:30 p.m.
Agenda: Report of Institute Director and
Institute Staff.
Place: National Human Genome Research
Institute, 6700B Rockledge Drive, Suite 1100,
Bethesda, MD 20892.
Closed: September 19, 2023, 10:00 a.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20892.
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 6700B Rockledge Drive, Suite 1100,
Rockville, MD 20892, (301) 402–0838,
[email protected].
Any interested person may file written
comments with the committee within 15
days after the meeting by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: http://
www.genome.gov/council, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

PO 00000

Number of
responses per
respondent

Fmt 4703

Sfmt 4703

Dated: July 26, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–16147 Filed 7–28–23; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for NIH Citizen Science and
Crowdsourcing Projects (Office of the
Director)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
[email protected] or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
ADDRESSES:

E:\FR\FM\31JYN1.SGM

31JYN1

49474

Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices

the data collection plans and
instruments, contact: Mikia Currie,
Chief, Project Clearance Branch, Office
of Policy and Extramural Research
Administration, Office of the Director,
Office of Extramural Research, NIH,
6705 Rockledge Drive, Bethesda,
Maryland 20892, MSC 7980, or call nontoll-free number (301) 435–0941 or
email your request, including your
address to: ProjectClearanceBranch@
mail.nih.gov.
This
proposed information collection was
previously published in the Federal
Register on February 14th, 2023, page
9527–9528 (88 FR 9527) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The Project
Clearance Branch, Office of Policy and
Extramural Research Administration,
Office of the Director, Office of
Extramural Research, National Institutes
of Health (NIH), may not conduct or
sponsor, and the respondent is not

SUPPLEMENTARY INFORMATION:

for flexible, innovative research
methods. The purpose of this
information collection is to:
• Accelerate scientific research
• Increase cost-effectiveness to
maximize the return on taxpayer
dollars
• Address societal needs
• Provide hands-on learning in STEM
education
• Connect members of the public
directly to federal science missions
and each other
• Identify and disseminate resources
more broadly to the public, on the
Institutes’ and Centers’ websites, and/
or
• Collect information for agency
internal use to improve scientific
practices and/or assist in scientific
reviews

required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid Office of Management
and Budget (OMB) control number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection: Generic
Clearance for NIH Citizen Science and
Crowdsourcing Projects—0925–0766—
07/31/2023 Extension, Project Clearance
Branch (PCB), Office of Policy and
Extramural Research Administration
(OPERA), Office of the Director (OD),
Office of Extramural Research (OER),
National Institutes of Health (NIH).
Need and Use of Information
Collection: Projects under this generic
clearance will continue to allow Agency
researchers and program staff to test
ideas more quickly, respond to the
project’s needs as they evolve, and
incorporate feedback from participants

OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
18,584.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of collection

Time per
response
(in hours)

Total hours

Call for Nominations/Resources ......................................................................
Recommendations of scientific reviewers .......................................................
Request for Population Characteristics ...........................................................
Repository of Tools and Best Practices ..........................................................

1,000
1,000
20,000
100,000

1
1
1
1

10/60
5/60
5/60
10/60

167
83
1,667
16,667

Total ..........................................................................................................

122,000

........................

........................

18,584

Dated: July 25, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–16185 Filed 7–28–23; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Meeting of the Substance Abuse and
Mental Health Services Administration
National Advisory Council
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
ddrumheller on DSK120RN23PROD with NOTICES1

Number of
responses per
respondent

Notice is hereby given for the
meeting on August 31, 2023, of the
Substance Abuse and Mental Health
Services Administration National
Advisory Council (SAMHSA NAC). The
meeting is open to the public and can

SUMMARY:

VerDate Sep<11>2014

18:11 Jul 28, 2023

Jkt 259001

also be accessed virtually. Agenda with
call-in information will be posted on the
SAMHSA website prior to the meeting
at: https://www.samhsa.gov/about-us/
advisory-councils/meetings. The
meeting will include, but not be limited
to, remarks from the Assistant Secretary
for Mental Health and Substance Use;
consideration and approval of the
meeting minutes of April 27, 2023;
updates and follow up from the
SAMHSA NAC meeting of April 27,
2023; recap of the joint meetings of the
councils (JNAC) and Lessons Learned;
presentations and council discussions
on the following topics: Kids Online
Health and Safety; Technical Assistance
and Training Strategy, and Strategic
Plan Updates; and a general council
discussion and public comments.
August 31, 2023, 10 a.m. to 4
p.m. EDT, Open.

DATES:

5600 Fishers Lane,
Rockville, Maryland 20857 (Pavilion
rooms).

ADDRESSES:

PO 00000

Frm 00041

Fmt 4703

Sfmt 4703

FOR FURTHER INFORMATION CONTACT:

Carlos Castillo, Committee Management
Officer and Designated Federal Official;
SAMHSA National Advisory Council,
5600 Fishers Lane, Rockville, Maryland
20857 (mail); telephone: (240) 276–
2787; email: carlos.castillo@
samhsa.hhs.gov.
The
SAMHSA NAC was established to
advise the Secretary, Department of
Health and Human Services (HHS), and
the Assistant Secretary for Mental
Health and Substance Use, SAMHSA, to
improve the provision of treatments and
related services to individuals with
respect to substance use and to improve
prevention services, promote mental
health, and protect legal rights of
individuals with mental illness and
individuals with substance use
disorders or misuse.
Interested persons may present data,
information, or views orally or in
writing, on issues pending before the
Council. Written submissions must be

SUPPLEMENTARY INFORMATION:

E:\FR\FM\31JYN1.SGM

31JYN1